Allosteric modulation company Addex Pharmaceuticals Ltd (Swiss:ADXN - News) announced today that Vincent Mutel, PhD, has stepped down from his position as CEO of the Addex group. Mr. André J. Mueller, ...
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Addex Therapeutics Ltd. Sponsored ADR (ADXN) been one of those stocks this year?
Indivior selected GABA B PAM drug candidate for development in substance use disorders (SUD) and starts IND enabling studies Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, November 22 ...
Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit
Geneva, Switzerland, September 19, 2024 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results